Sunshine Lake Pharma Moves Forward with Merger and Delisting of Yichang HEC Changjiang Pharmaceutical Co. Ltd., Announces Despatch of Composite Document

Reuters
06/29
Sunshine Lake Pharma Moves Forward with Merger and Delisting of Yichang HEC Changjiang Pharmaceutical Co. Ltd., Announces Despatch of Composite Document

Sunshine Lake Pharma Co., Ltd. has proposed a merger by absorption with Yichang HEC Changjiang Pharmaceutical Co., Ltd. This transaction involves Sunshine Lake Pharma acquiring Yichang HEC Changjiang Pharmaceutical, with a proposal to withdraw the latter's listing. The announcement was made jointly by Sunshine Lake Pharma and Yichang HEC Changjiang Pharmaceutical. The companies have released a composite document detailing the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 29, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10